The chemotherapy currently available for leishmaniasis is far from satisfactory. Resistance to
the pentavalent antimonials, which have been the recommended drugs for the treatment of …

Visceral leishmaniasis or Kala-azar is a vector-borne disease caused by an intracellular
parasite of the genus leishmania. In India, Amphotericin B (AmB) is a first-line medication for …

Drugs remain the most important tool for the treatment and control of both visceral and
cutaneous leishmaniasis. Although there have been several advances in the past decade …

Leishmaniasis is a parasitic disease caused by hemoflagellate, Leishmania spp. The
parasite is transmitted by the bite of an infected female phlebotomine sandfly. The disease is …

Introduction: Leishmaniasis is a parasitic disease transmitted by phlebotomine sandflies.
Between 700,000 and 1.2 million cases of cutaneous leishmaniasis and between 200,000 …

Leishmaniasis, a group of diseases caused by hemoflagellate obligate intracellular protozoa
(trypanosomatids) from the genus Leishmania, has not received the attention it deserves …

Visceral leishmaniaisis (kala-azar) is a disseminated protozoal infection, transmitted by
sandffy bite, in which macrophages of the liver, spleen, and bone marrow are preferentially …

The state of Bihar in India carries the largest share of the world's burden of antimony-
resistant visceral leishmaniasis. We analysed clinical studies done in Bihar with different …

The study of tropical diseases like leishmaniasis, a parasitic disease, has not received much
attention even though it is the second-largest infectious disease after malaria. As per the …

Background Leishmaniasis is increasingly reported among travellers. Leishmania species
vary in sensitivity to available therapies. Fast and reliable molecular techniques have made …